Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
7.95
+0.16 (2.05%)
At close: Apr 16, 2026, 4:00 PM EDT
8.00
+0.05 (0.63%)
After-hours: Apr 16, 2026, 4:58 PM EDT
Ginkgo Bioworks Holdings Market Cap
Ginkgo Bioworks Holdings has a market cap or net worth of $462.75 million as of April 16, 2026. Its market cap has increased by 49.33% in one year.
Market Cap
462.75M
Enterprise Value
480.01M
1-Year Change
49.33%
Ranking
Category
Stock Price
$7.95
Market Cap Chart
Since April 19, 2021, Ginkgo Bioworks Holdings's market cap has decreased from $2.18B to $462.75M, a decrease of -78.79%. That is a compound annual growth rate of -26.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 453.43M | -4.00% |
| Dec 31, 2025 | 472.31M | -9.39% |
| Dec 31, 2024 | 521.27M | -84.36% |
| Dec 29, 2023 | 3.33B | 16.75% |
| Dec 30, 2022 | 2.86B | -76.89% |
| Dec 31, 2021 | 12.35B | 466.18% |
| Apr 19, 2021 | 2.18B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Assembly Biosciences | 472.87M |
| Atea Pharmaceuticals | 468.47M |
| vTv Therapeutics | 468.09M |
| Benitec Biopharma | 465.87M |
| Century Therapeutics | 465.48M |
| Prelude Therapeutics | 455.59M |
| Aura Biosciences | 454.83M |
| Eupraxia Pharmaceuticals | 449.03M |